
|
Nicholas J. Stamato, M.D., FACC
Suite
250
30 Harrison Street
Johnson City, New York 13790-2143
Tel: (607) 770-8600
Fax: (607) 770-0853
Education:
B.A., Harpur College,
State University of New York at Binghamton
M.D.,
Upstate Medical
College,
State University of New York at Syracuse
Postgraduate Training and Fellowship Appointments:
Intern and Resident in Internal Medicine
University of Illinois Hospital
Chicago,
Illinois
Fellow in Cardiovascular Diseases
Loyola University Medical Center
Maywood, Illinois
Fellow in Cardiac Electrophysiology
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Fellow in Permanent Cardiac Pacing
Montefiore Hospital and Medical Center
Albert
Einstein School of Medicine
Bronx, New York
Specialty Certification:
Diplomate of the National Board of Medical Examiners
American Board of Internal Medicine
American Board of Internal Medicine
Cardiovascular Diseases
North American Society of Pacing and Electrophysiology,
Special Competency in Cardiac
Pacing
American Board of Internal Medicine
Critical Care Medicine
American Board of Internal Medicine
Clinical Cardiac Electrophysiology
American Board of Internal Medicine
Interventional Cardiology
Institute for Clinical
Evaluation
Credentialed in ECG Interpretation
Awards and Honors:
1972-76 New York State Regents Scholarship
1976 Graduation with Outstanding Academic Performance
1979 Knocker's Society Upstate Medical College
1984-85 Associate Chief Fellow in Cardiology
1986-87 Mark C. Lidwill Traveling Fellowship
North American Society of
Pacing and Electrophysiology
1993 Internal Medicine Residents Teaching Award
United Health Services Hospitals
1994 Internal Medicine Residents Teaching Award
United Health Services Hospitals
1997 Harpur College Alumni Award
1997 The Golden Apple Teaching Award
United Health Services Hospitals
1997 The Monsignor Peter J. Owens Volunteer of the Year Award
American
Heart Association
1998
President's Award for Voluntary Faculty Service
SUNY Health Science Center, Syracuse
2003 Alumni Who Have Made
a Difference
Award
Union Endicott High School
Memberships in Professional Societies:
Fellow, American College of Physicians
Fellow, American College of Cardiology
Fellow, American Heart Association Council on Clinical Cardiology
Fellow, American College of Chest Physicians
Fellow, Heart Rhythm Society
Fellow, Society for Cardiac Angiography and Interventions
Faculty Appointments:
19811983 Instructor in Medicine, University of Illinois
19871992 Assistant Professor of Clinical Medicine,
Loyola University Stritch School
of Medicine
19921995 Clinical Assistant Professor of Medicine,
SUNY-Health Science Center,
Syracuse
Clinical Campus at Binghamton
19952005 Clinical Associate Professor of Medicine
SUNY-Upstate Medical University at Syracuse
Clinical Campus at Binghamton
2005-present Clinical Professor of Medicine,
SUNY-Upstate Medical University at Syracuse
Clinical Campus at Binghamton
Administrative and Committee Appointments:
19891990 Utilization Review Committee,
Good Samaritan Hospital
19871992 Director of Pacemaker Clinic,
Midwest Heart Specialists, LTD
19881992 Medical Director, Midwest Heart Research Foundation
19891992 Board of Directors, Dupage Chapter, American Heart Association
19901992 Chairman, Heart at Work committee, Dupage Chapter, American Heart
Association
19901992 Affiliate Faculty American Heart Association of Metropolitan Chicago,
Advanced Cardiac Life Support
19901992 Secretary/Treasurer, American College of Cardiology, Illinois Chapter
19901992 Cardiovascular Medical Care Evaluation Committee, Good Samaritan Hospital
19911992 Chairman, Special Care Committee, Good Samaritan Hospital
1989 1998 Proctor, NASPExAM and NASPExAM Examination of Special Competency in
Cardiac Pacing
19921997 Director, Cardiac Electrophysiology Laboratory, Wilson Memorial Regional
Medical Center, United Health Services Hospitals
19921994 Consultant, Systems Users Group, C.R. Bard Electrophysiology
19921998 Dean's Committee for Clinical Research
19921994 Angioplasty and Electrophysiology Quality Assurance Committee, United
Health Services Hospitals
19931996 Committee for Clinical Research, United Health Services Hospitals
19931997 Critical Care Committee, United Health Services Hospitals
19931994 Building Fund Committee, North American Society of Pacing and
Electrophysiology
1993present Broome County Leadership Council, Midstate Region, New York State
Affiliate, American Heart Association
19931997 Steering Committee, Harpur College Health Professions Mentoring Program
19941997 Director of Cardiology, United Health Services Hospitals
19941996 Chairman, Section of Cardiology, Quality Assurance Committee
19941995 Binghamton University 50th Anniversary Fund Raising Committee
19952000 Coordinators/Executive Committee, SUNY-Clinical Campus at Binghamton
19962002 Trustee, United Health Services Foundation
19961999 President, Broome County Leadership Council, Midstate Region, New York
State Affiliate, American Heart Association
19962007 Member, Board of Directors, Binghamton University Foundation
1996-1999 President, Broome County Leadership Council,
Midstate Region, New York State Affiliate, American Heart Association
19992001 Vice-President, Board of Directors,
Binghamton University Foundation
1998-1999 Vice-Chair, Department of
Medicine
Our Lady of Lourdes
Hospital
2000-2002 Chair Department of Medicine
Our Lady of Lourdes Hospital
2002-2003 Treasurer of the Medical
Staff
Our Lady of Lourdes Hospital
2001-2005 President, Board of Directors
Binghamton University Foundation
2003- Present Director of
Cardiology
United Health Services Hospitals
Consultant Reviewer:
19851987 American Heart Journal
19932002 Catheterization and Cardiovascular Diagnosis
19932002 Pacing and Cardiac Electrophysiology (PACE)
2005-present Journal of Cardiovascular Electrophysiology
2007-present Clinical Cardiology
Investigatorships and Principal Investigatorships:
| Project: |
Sponsor: |
| Dobutamine Lactobionate for Congestive Heart Failure |
Eli Lilly |
| Sulotroban versus aspirin in Acute Myocardial Infarction |
Smith Kline & French |
| Cardizem SR for Hypertension |
Marion Labs |
| Legend Model 8416 8417 8418 Rate Responsive Pacemaker |
Medtronic |
| Permanent Pacer Lead Model 5078 Steroid Tip Active Fixation |
Medtronic |
| Pacesetter Model 3070 Temporary DDD Pacemaker |
Siemens Pacesetter |
| Ventak P AICD Model 1600 |
CPI |
Chicago Area Sudden Cardiac
Death Prevention Trial |
Chicago Chapter of the American Heart Association |
| Intravenous Amiodarone: Dose Ranging Trial |
Wyeth-Ayerst |
| Oral Ipazilide for Ventricular Tachycardia |
Sterling Research |
| Cardiac Arrhythmia Suppression Trial II (CAST II) |
National Institutes of Health |
| Oral Amiodarone for Refractory Atrial Fibrillation |
Wyeth-Ayerst |
| Oral Flosequinan for CHF |
Boots |
| Intravenous Amiodarone versus Bretylium for Ventricular
Arrhythmias |
Wyeth-Ayerst |
| Open label Amiodarone for Ventricular Arrhythmias |
Wyeth-Ayerst |
| Model 7217B Pacemaker Cardioverter Defibrillator (PCD) |
Medtronic |
| Multi-Center Unsustained Tachycardia Trial (MUSTT) |
National Institutes of Health |
| Bidisomide for Atrial Fibrillation |
Searle |
| Dofetilide for Atrial Fibrillation |
Pfizer |
| Dofetilide in Patients with an ICD |
Pfizer |
| Antiarrhythmics versus Implantable Defibrillators (AVID) |
National Institutes of Health |
| Thera VDD Pacemaker model 8948 and Lead Model 5032 |
Medtronic |
| ICD Lead Model 6932 |
Medtronic |
| Mode Selection Trial in Sinus Node Dysfunction (MOST) |
National Institutes of Health |
| Azimilide in Patients with an ICD |
Proctor and Gamble |
| ICD Lead Model 497-26 |
Sulzer Intermedics |
Fractal Pacemaker Leads
PX 53-BP/60-BP PX 45J-BP/53J-BP |
Biotronik |
| Sudden
Cardiac Death Heart Failure Trial (SCD-HeFT) |
National
Institutes of Health |
Bibliography
Original Publications:
Donovick PJ, Burright RG, Sikorsky RD, Stamato NJ, MacLaughlin WW: Cue elimination
effects on discrimination behavior of rats with septal lesions. Physiol Behavior 20 (1):
71-78, 1978.
Stamato NJ, O'Connell JC, Murdock DK, Moran JF, Loeb HS, Scanlon PJ: The response of
patients with complex ventricular arrhythmias secondary to dilated cardiomyopthy to
programmed electrical stimulation. Am Heart J 112 (3): 505-508, 1986.
Almendral JM, Rosenthal ME, Stamato NJ, Marchlinski FE, Buxton AE, Frame LH, Miller JM,
Josephson ME: Analysis of the resetting phenomenon in sustained uniform ventricular
tachycardia: Incidence and relation to termination. J Amer Coll Cardiol 8: 294-300, 1986.
Almendral JM, Stamato NJ, Rosenthal ME, Marchlinski FE, Buxton AE, Miller JM, Josephson
ME: Resetting response patterns during sustained ventricular tachycardia: Relationship to
the excitable gap. Circulation 74 (4): 722-730, 1986.
Rosenthal ME, Stamato NJ, Almendral JM, Marchlinski FE, Buxton AE, Miller JM, Josephson
ME: Influence of the site of stimulation on the resetting phenomenon in ventricular
tachycardia. Am J Cardiol 58: 970-976, 1986.
Stamato NJ, Rosenthal ME, Almendral JM, Josephson ME: The resetting response of
ventricular tachycardia to single and double extrastimuli: Implications for an excitable
gap. Am J Cardiol 60: 596-601, 1987.
Rosenthal ME, Stamato NJ, Almendral JM, Gottlieb CD, Josephson ME: Resetting of
ventricular tachycardia with electrocardiographic fusion: Incidence and significance.
Circulation 77: 581-588, 1988.
Rosenthal ME, Stamato NJ, Almendral JM, Gottlieb CD, Josephson ME: Coupling intervals
of ventricular extrastimuli causing resetting of sustained ventricular tachycardia
secondary to coronary artery disease: Relationship to subsequent termination. Am J Cardiol
61: 770-774, 1988.
Hartmann JR, McKeever LS, Bufalino VJ, Marek JC, Brown AS, Goodwin MJ, Colandrea MA,
Stamato NJ, Cahill JC, Amirparviz F: A system approach to intravenous thrombolysis in
acute myocardial infarction in community hospitals: The influence of paramedics. Clin
Cardiol 11: 812-816, 1988.
McKeever LS, Hartmann JR, Bufalino VJ, Marek JC, Brown AS, Goodwin MJ, Stamato NJ,
Cahill JM, Colandrea MA, Amirparviz F: Prolonged selective urokinase infusion in totally
occluded coronary arteries and bypass grafts: Two case reports. Catheterization and
Cardiovascular Diagnosis 15(4): 24-251, 1988.
Stamato NJ, Frame LH, Rosenthal ME, Almendral JM, Gottlieb CD, Josephson ME:
Procainamide-induced slowing of ventricular tachycardia with insights from analysis of
resetting response patterns. Am J Cardiol 63: 1455-1461, 1989.
McKeever LS, Hartmann JR, Bufalino VJ, Marek JC, Brown AS, Goodwin MJ, Colandrea MA,
Stamato NJ, Cahill JM, O'Donnell MJ, Amirparviz F, Enger E: Acute myocardial infarction
complicating recanalization of aortocoronary bypass grafts with urokinase therapy. Am J
Cardiol 64: 683-685, 1989.
Goodwin MJ, Hartmann JR, McKeever LS, Bufalino VJ, Marek JC, Brown AS, Colandrea MA,
Stamato NJ, Cahill JM, O'Donnell MJ, Amirparviz F, Enger E: Safety of intra-aortic balloon
counter-pulsation in patients with acute myocardial infarction receiving streptokinase
intravenously. Am J Cardiol 64: 937-938, 1989.
Hartmann JR, McKeever LS, Bufalino VJ, Marek JC, Brown AS, Goodwin MJ, Colandrea MA,
Stamato NJ, Cahill JM, O'Donnell MJ, Amirparviz F, Enger E: A randomized trial of
intravenous streptokinase versus tissue plasminogin activator for the treatment of acute
myocardial infarction: Results using an aggressive approach. J Interven Cardiol 3(2):
69-73, 1990.
Gottlieb CD, Rosenthal ME, Stamato NH, Frame LH, Lesh MD, Miller JM, Josephson ME: A
quantitative evaluation of refractoriness within a reentrant circuit during ventricular
tachycardia. Circulation 82: 1289-1295, 1990.
Hartmann JR, McKeever LS, Stamato NJ, Bufalino VJ, Marek JC, Brown AS, Goodwin MJ,
Cahill JM, Enger EL: Recanalization of chronically occluded aortocoronary saphenous vein
bypass grafts by extended infusion of urokinase: Initial results and one year follow-up. J
Amer Coll Cardiol 18 (6): 1517-1523, 1991.
McKeever LS, O'Donnell MJ, Stamato NJ, Cahill JM, Hartmann JR, Marek JC, Brown AS,
Enger EL: The effect of predilatation on coronary angioplasty induced vessel wall injury.
Am Heart J 122: 1515-1518, 1991.
Stamato NJ, O'Toole MF, Fetter JG, Enger EL: The safety and efficacy of chronic
ventricular pacing at 1.6 volts using steroid eluting lead. PACE 15:248-251, 1992.
The Cardiac Arrhythmia Suppression Trial II Investigators: Effect of the antiarrhythmic
agent Moricizine on survival after myocardial infarction. N Engl J Med 327: 227-233, 1992.
Stamato NJ, O'Toole MF, Valguisti E, Enger EL: A technique utilizing a steerable
hydrophilic guidewire for permanent pacemaker implantation. PACE 15: 1244-1247, 1992.
Stamato NJ, O'Toole MF, Enger EL: Permanent pacemaker implantation in the cardiac
catheterization laboratory versus the operating room: An analysis of hospital charges and
complications. PACE 15: 2236-2239, 1992.
Saksena S, and the PCD Investigator Group: Clinical outcome of patients with malignant
ventricular tachyarrhythmias and a multiprogrammable implantable
cardioverter-defibrillator implanted with or without thoracotomy: An International
multicenter study. J Am Coll Cardiol 23: 1521-1530, 1994.
Scheinman MM and the Intravenous Amiodarone Multicenter Investigators Group:
Dose-Ranging Study of Intravenous Amiodarone in patients with Life-Threatening Ventricular
Tachyarrhythmias. Circulation 92: 3264-3272, 1995.
Stamato NJ, Eddy SL, Whiting DJ: Transient complete heart block during radiofrequency
ablation of a left lateral bypass tract. PACE 19: 1351-1354, 1996.
The Antiarrhythmics
versus Implantable Defibrillators (AVID) Investigators. A Comparison of Antiarrhythmic-Drug
Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal
Ventricular Arrhythmias. N Engl J Med 337: 1576-83, 1997.
Buxton AE, Hafley GE, Lehmann MH, Gold M, OToole M,
Tang A, Coromilas J, Hook B, Stamato NJ, Lee KL: Prediction of Sustained Ventricular
Tachycardia Inducible by Programmed Stimulation in Patients with Coronary Artery Disease
Utility of Clinical Variables. Circulation. 99:1843-1850, 1999.
Malkin RA, Herre JM, McGowen L, Tenzer MM, Onufer JR,
Stamato NJ, Wood M, Berstein RC: A four-shock Bayesian up-down estimator of the 80%
effective defibrillation dose. J Cardiovasc Electrophysiol, 10(7):973-80, 1999.
Wyse
DG, Love JC, Yao Q, Carlson MD, Cassidy P, Greene LH,
Martins JB, Ocampo C, Raitt MH, Schron E, Stamato NJ,
Olarte A and the AVID Investigators: Atrial
Fibrillation: A Risk Factor for Increased Mortality – An
AVID Registry Analysis. Journal of Interventional
Cardiac Electrophysiology 5,267-273 2001.
Collins AT, Comeno CA,
Stamato NJ: Patterns of Use of Nicotine and Alcohol
in Patients with Implantable Cardioverter-Defibrillators
versus Coronary Artery Heart Disease Patients. HeartWeb Vol. 5, No. 7
February 2001. http://www.heartweb.org/heartweb/0301/p0001.htm
Russo AM, Hafley GE, Lee KL, Stamato NJ, Lehmann MH, Page
RL, Kus T, Buxton AE and the MUSTT Investigators:
Racial Differences in Outcome in the Multicenter
Unsustained Tachycardia Trial (MUSTT) A Comparison
of Whites versus Blacks. Circulation 2003; 108:67-72
.
Russo
AM, Stamato NJ, Lehmann MH, Hafley, GE, Lee, KL, Pieper K, Buxton AE,
and the MUSTT Investigators: Influence of Gender on Arrhythmia
Characteristics and Outcome in the Multicenter UnSustained Tachycardia
Trial. Journal of
Cardiovascular Electrophysiology 15 (9): 993-998, 2004.
Levy
R, DellaValle A,
Atav
AS
, Rehman A, Sklar AH, Stamato NJ
. The Relationship Between Glomerular Filtration Rate and Survival in
Patients Treated with an Implantable Cardioverter Defibrillator.
Clinical Cardiology (in press 2007).
Abstracts:
Stamato NJ, Rosenthal ME, Almendral JM, Josephson ME: Comparison of the resetting
response to single and double extrastimuli in ventricular tachycardia: Implications for an
excitable gap. J Amer Coll Cardiol 7 (2): 156A, 1996.
Stamato NJ, Rosenthal ME, Almendral JM, Josephson ME: Procainamide induced slowing of
ventricular tachycardia: Insights from analysis of resetting response patterns.
Circulation 74 (II): 313, 1986.
Rosenthal ME, Stamato NJ, Almendral JM, Miller JM, Marchlinski FE, Buxton AE, Josephson
ME: Determinates of the resetting phenomenon in ventricular tachycardia: Importance of
pacing site. PACE 9 (2): 281, 1986.
Almendral JM, Rosenthal ME, Stamato NJ, Josephson ME: Comparison of resetting and
termination of ventricular tachycardia with programmed extrastimuli. J Amer Coll Cardiol 7
(2): 243A, 1986.
Stamato NJ, Rosenthal ME, Gottlieb CD, Almendral JM, Josephson ME: Resetting response
patterns in ventricular tachycardia before and after procainamide: Implications for the
mechanism of tachycardia rate slowing. PACE 10 (2): 431, 1987.
Stamato NJ, Rosenthal ME, Almendral JM, Gottlieb CD, Josephson ME: Amiodarone induced
slowing of ventricular tachycardia: Insights from analysis of resetting response patterns.
J Amer Coll Cardiol 9(2): 48A, 1987.
Rosenthal ME, Stamato NJ, Almendral JM, Josephson ME: Relationship between resetting
and termination of sustained ventricular tachycardia: Implications for antitachycardia
pacing. J Amer Coll Cardiol 9(2): 167A, 1987.
Rosenthal ME, Stamato NJ, Almendral JM, Gottlieb CD, Josephson ME: Resetting of
ventricular tachycardia with electrocardiographic fusion: Incidence and significance. J
Amer Coll Cardiol 9(2): 153A, 1987.
Gottlieb CD, Rosenthal ME, Stamato NJ, Lesh M, Almendral JM, Josephson ME: The slope of
the resetting response curve predicts termination with extrastimuli in ventricular
tachycardia. Circulation 76(4): 219, 1987.
Stamato NJ, Josephson ME: Are posteroseptal bypass tracts longer than left lateral
bypass tracts? PACE 12(1): 685, 1989.
Fetter JG, Stamato NJ, Enger EL: Delays during pacemaker voltage programming changes
can result in erroneous threshold estimations. PACE 13: 525, 1990.
Stamato NJ, Haghighat A, Enger EL, Wenerski J: Analysis of P wave characteristics in
patients with prior atrial fibrillation compared to matched controls: Use of signal
averaging. PACE 14: 748, 1991.
Stamato NJ, Wenerski J, Enger EL: Signal average electrocardiograpy does not predict
findings at electrophysiologic study in high risk patients with
nonsustained ventricular
tachycardia and healed myocardial infarction. PACE 14: 748, 1991.
Stamato NJ, O'Toole MF, Enger EL: Permanent pacemaker implantation: Differences in
hospital charges when implantation is performed in the operating room versus the cardiac
catheterization laboratory. PACE 15(2): 509, 1992.
O'Toole MF, Roberts S, Bauman, Nazari J, Stamato NJ, Pham T: Does the response to
esmolol during tilt table testing predict efficacy of oral therapy? Chest 102(2): 212S,
1992.
Bernstein RC, Raymond LJ, Onufer JR, Stamato NJ, Wood MA, Ellenbogen KA, Tenzer MM,
Malkin RA, Herre JM: Factors Influencing Biphasic ED 80 Defibrillation Threshold
Determination. PACE 18(II): 872, 1995.
O'Toole M, Fetter C, Nora M, Shanks J, Rauh RA, Stamato NJ, Use of passive atrial leads
after open heart surgery. PACE 18(9 part II): 1777, 1995.
Shin H-T, Wyse DG, Rizo-Patron C, Stamato NJ, Daubert JP, Lancaster
S, Renfroe EG, Connors N, Pacifico A, Crevey B, Jennings C, Whiting D,
Yao Q, The AVID Investigators: Regional Differences in Utilization of
Implantable Cardioverter/defibrillators - An Antiarrhythmics Versus
Implantable defibrillators (AVID) Registry Study. J Amer Coll
Cardiol 31(2): 435A, 1998.
Wyse DG, Love JC, Yao
Q, Carlson MD, Cassidy P, Greene HL, Martins JB, Ocampo C, Raitt MH,
Schron EB, Stamato NJ: Atrial Fibrillation: A Risk Factor for
Increased Mortality in Patients with Ventricular Tachyarrthmias – An
AVID Registry Analysis. Circulation 98 (17) I-633, 1998.
Tullo NG, Stamato
NJ, Reiter M, Reiffel J, Goldner B, Bigger JT, Rosenberg Y, Whiting D,
Graham-Renfroe E, Ledingham RB, Hallstrom A, AVID Investigators: Prior
Antiarrhythmic Drug Use Does Not Predict Survival but Does Affect Impact
of Implantable Cardioverter-Defibrillators: Analysis of the
Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.
Circulation 100(18) I-570, 1999.
Russo AM, Stamato NJ, Pieper KS: Gender Differences in the Multicenter
Unsustained Tachycardia Trial. Circulation 100(18) I-657, 1999.
Russo AM, Hafley GE,
Lee KL, Stamato N, Lehman M, Page RL, Kus T, Batsford W, Rubin D, Buxton
AE, and the MUSTT Investigators. Lower ICD use in Minorities
Results in worse Outcomes: Racial/Cultural Variations in the Multicenter
Unsustained Tachycardia Trial. Circulation 102(18) I-674, 2000.
Reviews and Chapters:
Stamato NJ, Josephson ME: When and how to manage premature ventricular contractions. J
Critical Illness 1(6): 41-48, 1986.
Stamato NJ, Marchlinski FE: Role of Holter monitors in the management of patients with
ventricular tachycardia treated with amiodarone. Clinical Progress in Electrophysiology
and Pacing 4(5): 395-401, 1986.
Stamato NJ, Josephson ME: Invasive electrophysiologic studies in the evaluation and
treatment of patients with ventricular arrhythmias. In Kapoor AS (ed): Interventional
Cardiology. New York: Springer-Verlag, pp 119-132, 1989.
Iverson WR, Hartmann JR, Foy BK, Stamato NJ: AICDs spark hope for cardiac care. J Emerg
Med Ser (JEMS) 14(9): 36-40, 1989.
Stamato NJ: The safety and efficacy of programming low output settings with steroid
eluting leads. Medtronic News 21(1): 29-31, 1992.
Hartmann JR, Armirparviz F, McKeever LS, Stamato NJ, Enger EL: Recanalization of
chronically occluded saphenous vein aortocoronary bypass grafts: The role of thrombolysis.
Primary Cardiology 19(3): 19-31, 1993.
Stamato NJ, Doerner LJ, De Simone RJ: Your EP Study: The Quest for Knowledge. Patient
teaching video tape. Bard electrophysiology, 1993.
Buxton AE, Fisher JD, Josephson ME, Lee KL, Pryor DB, Prystowsky EN, Simson MB, DiCarlo
L, Echt DS, Packer D, Greer GS, Talajic M and the MUSTT Investigators: Prevention of
Sudden Cardiac Death in patients with coronary artery disease: The Multicenter Unsustained
Tachycardia Trial (MUSTT). Progress in Cardiovascular Disease 36(3): 215-226, 1993.
Case Reports and Letters:
Stamato NJ, O'Connell JB, Subramainian R, Scanlon PJ: The diagnosis of endocardial
fibroelastosis made by endomyocardial biopsy in an adult with dilated cardiomyopthy. Am
Heart J 109(4): 119-220, 1985.
Rosenthal ME, Stamato NJ, Marchlinski FE, Josephson ME: Noninvasive cardiac pacing for
termination of sustained uniform ventricular tachycardia. Am J Cardiol 58(6): 561-562,
1986.
LaBarre TR, Stamato NJ, Hwang MH, Jacobs WR, Stephanides L, Scanlon PJ: Left atrial
appendage aneurysm with associated anomalous pulmonary venous drainage. Am Heart J 114(5):
1243-1245, 1987.
Stamato NJ, Cahill JM, Goodwin MJ, Winters G: Cardiac amyloidosis causing ventricular
tachycardia: Diagnosis made by endomyocardial biopsy. Chest 96(6): 1431-1433, 1989.
Stamato NJ, Goodwin MJ, Foy BF: Diagnosis of coronary sinus diverticulum in
Wolff-Parkinson-White Syndrome using coronary angiography. PACE 12 1589-1591, 1989.
McKeever LS, Marek J, Stamato NJ: Emergency operation after failed angioplasty. (Letter
to the Editor) Journal of Throracic and Cardiovascular Surgery 98: 151, 1989.
Stamato NJ, Eddy SL, Rawoof SA, Whiting DJ, Cunningham JR, Song J: Sensing of a
Transcutaneous Nerve stimulator by an ICD Device. Heart Web. On the internet at:
http://webaxis.com/heartweb/ June 28, 1996.
|